ICICI Securities has issued a price target of ₹640 for Archean Chemical Industries, citing the company's strategic entry into the semiconductor sector as a key growth driver. While the long-term outlook focuses on its new Silicon Carbide facility, investors should note the company's recent profit margin compression and rising promoter share pledging.
ICICI Securities has issued a 'Buy' rating on Archean Chemical Industries with a target price of ₹640, suggesting a potential 35% upside from current market levels. The brokerage's positive outlook is largely tied to the company's strategic move into the semiconductor industry, which marks a significant shift from its traditional specialty chemicals business.
At the center of this strategy is the company’s subsidiary, SiCSem, which is developing a ₹2,067 crore integrated Silicon Carbide (SiC) facility in Bhubaneswar, Odisha. This project aims to establish one of the first integrated domestic plants capable of handling both SiC fabrication and assembly, testing, marking, and packaging processes. In May 2026, the company signed a Fiscal Support Agreement with the India Semiconductor Mission, a move intended to help the firm tap into the growing domestic demand for semiconductor chips and reduce reliance on imports.
While the semiconductor expansion provides a long-term growth narrative, the company’s core specialty chemicals business has faced recent headwinds. In the first quarter of fiscal year 2027, the company reported standalone revenue of ₹315.93 crore. Profitability during this period has been under pressure due to elevated logistics costs and volatile pricing for its bromine and industrial salt products. Analysts are now looking for a recovery in bromine production volumes to help stabilize the core operations and improve margins in the coming quarters.
Investors should also consider the financial risks associated with the company’s current structure. A notable concern is the level of promoter pledging, which reached 24.49% of promoter holdings as of June 2026. High levels of pledged shares can create financial constraints and add to investor anxiety during periods of stock price volatility.
Furthermore, the semiconductor project is still in the early stages of development. The company faces significant execution risks, including the challenge of managing a large-scale infrastructure project, the potential for cost overruns, and the long timeline required to reach full production capacity. For those tracking the stock, the key monitorables will be the construction progress of the Bhubaneswar facility, the company’s ability to control rising logistics expenses, and updates on the promoter pledging situation.